← Eichor
Study identifier: NCT03826264 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Transpacific TAVR Registry

Condition: Heart Valve Diseases · Aortic Valve Insufficiency  ·  Sponsor: Duk-Woo Park, MD

PhaseN/A
Planned participants10000
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.

This description comes directly from the study's public registry record.

Talk to the study team

Duk-woo Park, MD  ·  82230103995  ·  dwpark@amc.seoul.kr

Do-yoon Kang, MD  ·  kdy1218@gmail.com

Always discuss trial participation with your own doctor first.

Locations (7)

Stanford UniversityStanford, California, United StatesRecruiting
Northwestern Memorial HospitalChicago, Illinois, United StatesRecruiting
Second Affiliated Hospital of Zhejiang UniversityHangzhou, ChinaRecruiting
Bucheon Sejong HospitalBucheon-si, South KoreaActive Not Recruiting
Chungnam National University HospitalDaejeon, South KoreaRecruiting
Asan Medical CenterSeoul, South KoreaRecruiting
Seoul National University HospitalSeoul, South KoreaCompleted

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03826264